MedTrace Logo

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

NCT06049758 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-09-22

No results posted yet for this study

Summary

Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years

Conditions

  • Blood Loss
  • Intensive Care
  • Anastomotic Leakage
  • Lymph Node Disease
  • Survival
  • Blood Transfusion

Interventions

PROCEDURE

LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy

DRUG

Enoxaparin 40 Mg/0.4 mL Injectable Solution

Enoxaparin sodium 40 mg subcutaneous injection will be administered 12 hours before the operation

DRUG

Levofloxacin 500mg

Levofloxacin 500 mg intravenous injection will be administered 1 hour before the operation.

PROCEDURE

LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy

Sponsors & Collaborators

  • General Committee of Teaching Hospitals and Institutes, Egypt

    lead OTHER_GOV

Principal Investigators

  • Medhat Mohamed Anwar Hamed, Prof · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-02
Primary Completion
2026-01-02
Completion
2030-01-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06049758 on ClinicalTrials.gov